GlassScriptPhysician profile
Michael Samuel Cicchillo
NPI 1922033901
$5,892.14
in general payments reported to CMS, 2019-2025
32 companies · $1,784 in 2025
The $1,784 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $130 · 2021: $528 · 2023: $1,440 · 2024: $1,657 · 2025: $1,784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,880.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,654.07 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $1,561.37 | 2019-2025 | Zenith Spiral-Z, Cook, Zilver Ptx |
| Shockwave Medical, INC | $522.27 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $470.74 | 2021-2025 | Ovation Ix Iliac Stent Graft, Afx2 Bifurcated Endograft System, Torus Stent Graft System |
| Medtronic, INC. | $389.95 | 2021-2023 | Heli-Fx Endoanchor System |
| Imperative Care, INC | $161.88 | 2025 | Prodigy Catheter, Symphony Catheter |
| Boston Scientific Corporation | $142.54 | 2021-2025 | Enroute Transcarotid Stent |
| Bolton Medical INC | $104.24 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Ethicon US, LLC | $97.17 | 2025 | Echelon Circular |
| Atricure, INC. | $95.62 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Pfizer INC. | $68.74 | 2019 | |
| Angiodynamics, INC. | $65.86 | 2021 | |
| Cagent Vascular INC | $50.40 | 2025 | Serrantor |
| Solventum Corporation | $46.22 | 2024 | V.A.C. Dermatac, Activ.A.C., Prevena |
| Amgen INC. | $45.10 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $43.97 | 2025 | Cutimed Sorbact |
| E.R. Squibb & Sons, L.L.C. | $35.52 | 2019 | |
| Lemaitre Vascular, INC. | $34.94 | 2023-2025 | Restoreflow |
| Convatec INC. | $34.88 | 2024 | |
| Bard Peripheral Vascular, INC. | $30.77 | 2023 | Venclose Maven Catheter |
| Smith+Nephew, INC. | $28.89 | 2019-2025 | Collagenase Santyl |
| Terumo Medical Corporation | $28.76 | 2019-2025 | Angio-Seal |
| Surmodics, INC. | $23.73 | 2023-2024 | Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Acera Surgical, INC. | $21.10 | 2024 | Restrata Wound Matrix |
| Ekos Corporation | $20.18 | 2019 | |
| Artivion, INC. | $19.18 | 2024 | Photofix Decellularized Bovine Pericardium, Vascular, Bioglue Surgical Adhesive |
| Organogenesis INC. | $17.83 | 2019 | |
| Integra Lifesciences Corporation | $16.44 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Silk Road Medical, INC. | $15.92 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Teleflex LLC | $14.97 | 2025 | Quikclot |
| Astrazeneca Pharmaceuticals LP | $14.77 | 2019 | |
| Cardinal Health 200 LLC | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cicchillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.